The Cancer Letter

Inside information on cancer research and drug development

In Brief

Patient groups applaud circuit court ruling that largely stays remedy in Braidwood Management v. Becerra

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The U.S. Court of Appeals for the Fifth Circuit approved an agreement by the parties on a stay of the remedy in the case of Braidwood v. Becerra, pausing the effect of the lower court’s ruling that threatens access to U.S. Preventive Services Task Force recommended preventive services without cost sharing as required under the Affordable Care Act. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

Medicaid expansion may improve cancer care and survival for people with HR-negative, HER2-positive breast cancer

New research published in the Journal of the National Comprehensive Cancer Network found that people with newly-diagnosed hormone receptor-negative, human epidermal growth factor receptor 2-positive breast cancer were more likely to receive timely, guideline-concordant treatment, and have longer survival in states that participate in Medicaid expansion under the Affordable Care Act.
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account